» Articles » PMID: 39085047

The Rise and Future of CRISPR-based Approaches for High-throughput Genomics

Overview
Specialty Microbiology
Date 2024 Jul 31
PMID 39085047
Authors
Affiliations
Soon will be listed here.
Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR) has revolutionized the field of genome editing. To circumvent the permanent modifications made by traditional CRISPR techniques and facilitate the study of both essential and nonessential genes, CRISPR interference (CRISPRi) was developed. This gene-silencing technique employs a deactivated Cas effector protein and a guide RNA to block transcription initiation or elongation. Continuous improvements and a better understanding of the mechanism of CRISPRi have expanded its scope, facilitating genome-wide high-throughput screens to investigate the genetic basis of phenotypes. Additionally, emerging CRISPR-based alternatives have further expanded the possibilities for genetic screening. This review delves into the mechanism of CRISPRi, compares it with other high-throughput gene-perturbation techniques, and highlights its superior capacities for studying complex microbial traits. We also explore the evolution of CRISPRi, emphasizing enhancements that have increased its capabilities, including multiplexing, inducibility, titratability, predictable knockdown efficacy, and adaptability to nonmodel microorganisms. Beyond CRISPRi, we discuss CRISPR activation, RNA-targeting CRISPR systems, and single-nucleotide resolution perturbation techniques for their potential in genome-wide high-throughput screens in microorganisms. Collectively, this review gives a comprehensive overview of the general workflow of a genome-wide CRISPRi screen, with an extensive discussion of strengths and weaknesses, future directions, and potential alternatives.

References
1.
Kushawah G, Hernandez-Huertas L, Abugattas-Nunez Del Prado J, Martinez-Morales J, DeVore M, Hassan H . CRISPR-Cas13d Induces Efficient mRNA Knockdown in Animal Embryos. Dev Cell. 2020; 54(6):805-817.e7. DOI: 10.1016/j.devcel.2020.07.013. View

2.
Ghosh S, Lahiri D, Nag M, Sarkar T, Pati S, Edinur H . Precision targeting of food biofilm-forming genes by microbial scissors: CRISPR-Cas as an effective modulator. Front Microbiol. 2022; 13:964848. PMC: 9396135. DOI: 10.3389/fmicb.2022.964848. View

3.
Casas-Mollano J, Zinselmeier M, Erickson S, Smanski M . CRISPR-Cas Activators for Engineering Gene Expression in Higher Eukaryotes. CRISPR J. 2020; 3(5):350-364. PMC: 7580621. DOI: 10.1089/crispr.2020.0064. View

4.
Eckartt K, Delbeau M, Munsamy-Govender V, DeJesus M, Azadian Z, Reddy A . Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis. Nature. 2024; 628(8006):186-194. PMC: 10990936. DOI: 10.1038/s41586-024-07206-5. View

5.
Yu L, Su W, Fey P, Liu F, Du L . Yield Improvement of the Anti-MRSA Antibiotics WAP-8294A by CRISPR/dCas9 Combined with Refactoring Self-Protection Genes in Lysobacter enzymogenes OH11. ACS Synth Biol. 2017; 7(1):258-266. PMC: 5775038. DOI: 10.1021/acssynbio.7b00293. View